tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA

Compare Palvella Therapeutics (PVLA) vs. Competitors

779 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Palvella Therapeutics
$123.17
$1.86B
-28.23
497.25%
13 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$16.60
$852.21M
3.90
94.02%
3 Buy
3 Hold
0 Sell
Moderate Buy
Monopar Therapeutics Inc
$58.03
$387.61M
-35.28
77.56%
7 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$15.60
$1.68B
-5.04
69.17%
11 Buy
0 Hold
0 Sell
Strong Buy
Terns Pharmaceuticals
$52.66
$6.07B
2185.22%
0 Buy
9 Hold
0 Sell
Hold
Tyra Bioscience
$37.13
$1.98B
-13.06
363.26%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PVLA
Palvella Therapeutics
130.20
108.44
498.35%
TBPH
Theravance Biopharma
16.55
8.15
97.02%
MNPR
Monopar Therapeutics Inc
57.92
23.03
66.01%
NRIX
Nurix Therapeutics
16.24
7.10
77.68%
TERN
Terns Pharmaceuticals
52.56
50.42
2356.07%
TYRA
Tyra Bioscience
36.69
28.73
360.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts